Association of fractures with the incidence of amyotrophic lateral sclerosis

References

• Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617–28.
   PubMed Web of Science ®Google Scholar
• Campbell AM, Williams ER, Barltrop D. Motor neurone disease and exposure to lead. J Neurol Neurosurg Psychiatr. 1970;33:877–85.
   PubMed Web of Science ®Google Scholar
• Kurtzke JF, Beebe GW. Epidemiology of amyotrophic lateral sclerosis: 1. A case-control comparison based on ALS deaths. Neurology. 1980;30:453–62.
   PubMed Web of Science ®Google Scholar
• Angelini C, Armani M, Bresolin N. Incidence and risk factors of motor neuron disease in the Venice and Padua districts of Italy, 1972-1979. Neuroepidemiology. 1983;2:236–42.
   Google Scholar
• Gawel M, Zaiwalla Z, Rose FC. Antecedent events in motor neuron disease. J Neurol Neurosurg Psychiatr. 1983;46:1041–3.
   PubMed Web of Science ®Google Scholar
• Gresham LS, Molgaard CA, Golbeck AL, Smith R. Amyotrophic lateral sclerosis and occupational heavy metal exposure: a case-control study. Neuroepidemiology. 1986;5:29–38.
   PubMedGoogle Scholar
• Granieri E, Carreras M, Tola R, Paolino E, Tralli G, Eleopra R, et al. Motor neuron disease in the province of Ferrara, Italy, in 1964-1982. Neurology. 1988;38:1604–8.
   PubMed Web of Science ®Google Scholar
• Savettieri G, Salemi G, Arcara A, Cassata M, Castiglione MG, Fierro B. A case-control study of amyotrophic lateral sclerosis. Neuroepidemiology. 1991;10:242–5.
   PubMed Web of Science ®Google Scholar
• Gunnarsson LG, Bodin L, Soderfeldt B, Axelson O. A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents. Br J Ind Med. 1992;49:791–8.
   PubMedGoogle Scholar
• Chancellor AM, Slattery JM, Fraser H, Warlow CP. Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatr. 1993;56:1200–6.
   PubMed Web of Science ®Google Scholar
• Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs RI. Physical activity, trauma, and ALS: a case-control study. Acta Neurol Scand. 1996;94:45–50.
   PubMed Web of Science ®Google Scholar
• Cruz DC, Nelson LM, McGuire V, Longstreth WT Jr, Physical trauma and family history of neurodegenerative diseases in amyotrophic lateral sclerosis: a population-based case-control study. Neuroepidemiology. 1999;18:101–10.
   PubMed Web of Science ®Google Scholar
• Kihira T, Kanno S, Miwa H, Okamoto K, Kondo T. The role of exogenous risk factors in amyotrophic lateral sclerosis in Wakayama, Japan. Amyotroph Lateral Scler Other Motor Neuron Disord. 2007;8:150–6.
   PubMed Web of Science ®Google Scholar
• Pupillo E, Messina P, Logroscino G, Zoccolella S, Chio A, Calvo A, et al. Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry. Eur J Neurol. 2012;19:1509–17.
   PubMed Web of Science ®Google Scholar
• Seals RM, Hansen J, Gredal O, Weisskopf MG. Physical trauma and amyotrophic lateral sclerosis: A population-based study using Danish national registries. Am J Epidemiol. 2015;183:294–301.
   Web of Science ®Google Scholar
• van Geel TA, van den Bergh JP, Dinant GJ, Geusens PP. Individualizing fracture risk prediction. Maturitas. 2010;65:143–8.
   PubMed Web of Science ®Google Scholar
• Ensrud KE. Epidemiology of fracture risk with advancing age. J Gerontol A Biol Sci Med Sci. 2013;68:1236–42.
   PubMed Web of Science ®Google Scholar
• Fang F, Kwee LC, Allen KD, Umbach DM, Ye W, Watson M, et al. Association between blood lead and the risk of amyotrophic lateral sclerosis. Am J Epidemiol. 2010;171:1126–33.
   PubMed Web of Science ®Google Scholar
• Mallette LE, Patten B, Cook JD, Engel WK. Calcium metabolism in amyotrophic lateral sclerosis. Dis Nerv Syst. 1977;38:457–61.
   PubMedGoogle Scholar
• Melmed S, Braunstein GD. Endocrine function in amyotrophic lateral sclerosis. A review. Neurol Clin. 1987;5:33–42.
   PubMed Web of Science ®Google Scholar
• Sato Y, Honda Y, Asoh T, Kikuyama M, Oizumi K. Hypovitaminosis D and decreased bone mineral density in amyotrophic lateral sclerosis. Eur Neurol. 1997; 37:225–9.
   PubMed Web of Science ®Google Scholar
• Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68:857–64.
   PubMed Web of Science ®Google Scholar
• Lagerlund M, Bellocco R, Karlsson P, Tejler G, Lambe M. Socio-economic factors and breast cancer survival–a population-based cohort study (Sweden). Cancer Causes Control. 2005;16:419–30.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
   PubMed Web of Science ®Google Scholar
• Statistics SwedenThe Swedish register of education [Internet]. Sweden: Statistics Sweden. 2004 [updated 2004 December 23; cited 2016 November 17]. Available from: http://www.scb.se/statistik/UF/UF0506/Produktbeskrivning_short_English_UF0506_20040101r.doc
   Google Scholar
• Ludvigsson JF, Almqvist C, Bonamy AK, Ljung R, Michaelsson K, Neovius M, et al. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016; 31:125–36.
   PubMed Web of Science ®Google Scholar
• Kurian KM, Forbes RB, Colville S, Swingler RJ. Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register. J Neurol Neurosurg Psychiatr. 2009;80:84–7.
   PubMed Web of Science ®Google Scholar
• St Germaine-Smith C, Metcalfe A, Pringsheim T, Roberts JI, Beck CA, Hemmelgarn BR, et al. Recommendations for optimal ICD codes to study neurologic conditions: a systematic review. Neurology. 2012;79:1049–55.
   PubMed Web of Science ®Google Scholar
• Gardner RC, Yaffe K. Epidemiology of mild traumatic brain injury and neurodegenerative disease. Mol Cell Neurosci. 2015;55:75–80.
   Web of Science ®Google Scholar
• Brennan SL, Holloway KL, Williams LJ, Kotowicz MA, Bucki-Smith G, Moloney DJ, et al. The social gradient of fractures at any skeletal site in men and women: data from the Geelong Osteoporosis Study Fracture Grid. Osteoporos Int. 2015;26:1351–9.
   PubMed Web of Science ®Google Scholar
• Sutedja NA, Veldink JH, Fischer K, Kromhout H, Wokke JH, Huisman MH, et al. Lifetime occupation, education, smoking, and risk of ALS. Neurology. 2007;69:1508–14.
   PubMed Web of Science ®Google Scholar
• Roos PM. Osteoporosis in neurodegeneration. J Trace Elem Med Biol. 2014;28:418–21.
   PubMed Web of Science ®Google Scholar
• Jackson CE, Amato AA, Bryan WW, Wolfe GI, Sakhaee K, Barohn RJ. Primary hyperparathyroidism and ALS: is there a relation? Neurology. 1998;50:1795–9.
   PubMed Web of Science ®Google Scholar
• Karam C, Barrett MJ, Imperato T, MacGowan DJ, Scelsa S. Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis. J Clin Neurosci. 2013;20:1550–3.
   PubMed Web of Science ®Google Scholar
• Camu W, Tremblier B, Plassot C, Alphandery S, Salsac C, Pageot N, et al. Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis. Neurobiol Aging. 2014;35:1198–205.
   PubMed Web of Science ®Google Scholar
• Gianforcaro A, Hamadeh MJ. Dietary vitamin D3 supplementation at 10x the adequate intake improves functional capacity in the G93A transgenic mouse model of ALS, a pilot study. CNS Neurosci Ther. 2012;18:547–57.
   PubMed Web of Science ®Google Scholar
• Long K, Nguyen LT. Roles of vitamin D in amyotrophic lateral sclerosis: possible genetic and cellular signaling mechanisms. Mol Brain. 2013;6:16.
   PubMed Web of Science ®Google Scholar
• ALS Untangled No. 24: Vitamin D. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:318–20.
   PubMed Web of Science ®Google Scholar
• Kamel F, Umbach DM, Hu H, Munsat TL, Shefner JM, Taylor JA, et al. Lead exposure as a risk factor for amyotrophic lateral sclerosis. Neurodegener Dis. 2005;2:195–201.
   PubMed Web of Science ®Google Scholar
• Hu H, Payton M, Korrick S, Aro A, Sparrow D, Weiss ST, et al. Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men. The normative aging study. Am J Epidemiol. 1996;144:749–59.
   PubMed Web of Science ®Google Scholar
• Nash D, Magder LS, Sherwin R, Rubin RJ, Silbergeld EK. Bone density-related predictors of blood lead level among peri- and postmenopausal women in the United States: The Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2004;160:901–11.
   PubMed Web of Science ®Google Scholar
• Gulson BL, Mizon KJ, Korsch MJ, Palmer JM, Donnelly JB. Mobilization of lead from human bone tissue during pregnancy and lactation-a summary of long-term research. Sci Total Environ. 2003;303:79–104.
   PubMed Web of Science ®Google Scholar
• Escribano A, Revilla M, Hernandez ER, Seco C, Gonzalez-Riola J, Villa LF, et al. Effect of lead on bone development and bone mass: a morphometric, densitometric, and histomorphometric study in growing rats. Calcif Tissue Int. 1997;60:200–3.
   PubMed Web of Science ®Google Scholar
• Beier EE, Maher JR, Sheu TJ, Cory-Slechta DA, Berger AJ, Zuscik MJ, et al. Heavy metal lead exposure, osteoporotic-like phenotype in an animal model, and depression of Wnt signaling. Environ Health Perspect. 2013;121:97–104.
   PubMed Web of Science ®Google Scholar
• Campbell JR, Rosier RN, Novotny L, Puzas JE. The association between environmental lead exposure and bone density in children. Environ Health Perspect. 2004;112:1200–3.
   PubMed Web of Science ®Google Scholar